Amalio Telenti

Dr. Telenti led the study of the first 10,000 human genomes that underwent deep sequencing (Telenti et al. PNAS 2016), as well as key studies on the essentiality of coding and non-coding genome elements (Bartha et al. PLoS Comp Biol 2015, Bartha et al. Nat Rev Genet 2018, di Iulio et al. Nat Genet 2018). His lab contributes approaches for the integration of genomic and other data modalities, in particular metabolome and microbiome (Long et al. Nat Genet 2017, Moustafa et al. PLoS Pathogens 2017, Cirulli et al. Cell Metab 2018) and for the joint analyses of two genomes (Bartha et al. eLife 2013). In previous years, the Telenti lab led research in host-pathogen genomics (Fellay et al. Science 2007, Loeuillet et al. PLoS Biol 2008, Rotger et al. J Clin Invest 2011), and earlier, on the genomics of drug resistance (Telenti et al. Lancet 1993, Takiff et al. Antimicrob Agents Chem 1994, Telenti et al. Nat Med 1997).